The Prenylflavonoid Xanthohumol Reduces Alzheimer-Like Changes and Modulates Multiple Pathogenic Molecular Pathways in the Neuro2a/APPswe Cell Model of AD

Abstract

Alzheimer’s disease (AD) is a progressive neurodegenerative disorder that has proved refractory to drug treatment. Given evidence of neuroprotection in animal models of ischemic stroke, we assessed the prenylflavonoid xanthohumol from the Common Hop (Humulus lupulus L.) for therapeutic potential in murine neuroblastoma N2a cells stably expressing human Swedish mutant amyloid precursor protein (N2a/APP), a well-characterized cellular model of AD. The ELISA and Western-blot analysis revealed that xanthohumol (Xn) inhibited Aβ accumulation and APP processing, and that Xn ameliorated tau hyperphosphorylation via PP2A, GSK3β pathways in N2a/APP cells. The amelioration of tau hyperphosphorylation by Xn was also validated on HEK293/Tau cells, another cell line with tau hyperphosphorylation. Proteomic analysis (2D-DIGE-coupled MS) revealed a total of 30 differentially expressed lysate proteins in N2a/APP vs. wild-type (WT) N2a cells (N2a/WT), and a total of 21 differentially expressed proteins in lysates of N2a/APP cells in the presence or absence of Xn. Generally, these 51 differential proteins could be classified into seven main categories according to their functions, including: endoplasmic reticulum (ER) stress-associated proteins; oxidative stress-associated proteins; proteasome-associated proteins; ATPase and metabolism-associated proteins; cytoskeleton-associated proteins; molecular chaperones-associated proteins, and others. We used Western-blot analysis to validate Xn-associated changes of some key proteins in several biological/pathogenic processes. Taken together, we show that Xn reduces AD-related changes in stably transfected N2a/APP cells. The underlying mechanisms involve modulation of multiple pathogenic pathways, including those involved in ER stress, oxidative stress, proteasome molecular systems, and the neuronal cytoskeleton. These results suggest Xn may have potential for the treatment of AD and/or neuropathologically related neurodegenerative diseases.

Mori Cortex Radicis Attenuates High Fat Diet-Induced Cognitive Impairment via an IRS/Akt Signaling Pathway

“…It has been previously reported MCR contains the prenylflavonoids, such as cyclomulberrin, morusin, sanggenonI, and kuwanonU [30] and that the prenyl group attached to the flavonoid backbone increases bioactivity by interacting with biological membranes and target proteins [31]. Much evidence supports the ROS scavenging effects of prenylflavonoids, and many plants containing prenylflavonoids are of medicinal interest (e.g., Herba epimedii, hop, and licorice) and exhibit antioxidant effects [32][33][34]. In addition, our previous study demonstrated that MCR inhibited oxidative stress and the apoptosis of neuronal PC12 cells [10,11].…”

Estrogenic Plants: to Prevent Neurodegeneration and Memory Loss and Other Symptoms in Women After Menopause

“…Proteomic analysis by mass spectrometry revealed 30 proteins differentially expressed in the N2a/APP when compared to wild-type (WT) N2a cells (N2a/WT), and a total of 21 differentially expressed proteins in lysates of N2a/APP cells treated with xanthohumol. This treatment reduced AD-like changes in the proteome of N2a/APP cells, affecting proteins involved in endoplasmic reticulum stress, cytoskeleton, oxidative stress, and proteasome therapeutic potential of xanthohumol for treatment of AD and/or other tauopathies ( Huang et al, 2018 ). Colupulone, a prenylated phloroglucinol obtained from Humulus lupulus, activates the pregnane-X-receptor (PXR), a nuclear receptor controlling the expression P-gp a protein that controls the transport troghout the Blood-brain barrier (BBB).…”

The Nutritional Components of Beer and Its Relationship with Neurodegeneration and Alzheimer’s Disease

“…Xanthohumol has been defined as a very important compound of hops and beer due to its positive effects as an antioxidant and neuroprotective described in some central papers [148]. In this line, Huang et al [137] found several metabolic pathways where prenylflavonoid xantuhumol can be engaged as protective in some neurodegenerative diseases, such as Alzheimer's (e.g. through inhibiting the Aβ accumulation and APP processing, and inducing amelioration of tau hyperphosphorilation via PP2A, GSK3β pathways in N2a/APP cells).…”